ITRM   $0.0704  97.75% Market Closed After Close 0.06665 -5.33%

Iterum Therapeutics plc
Total Cash 11.72M
totalCashPerShare 0.516
EBITDA -37.36M
Total Debt 21.62M
quickRatio 0.71
currentRatio 0.816
Total Revenue
debtToEquity
Revenue/Share
ROA -0.73347
ROE
grossProfits
freeCashflow -28.46M
operatingCashflow -41.95M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 39.19M
forwardPE -1.8484849
floatShares 21.96M
sharesOutstanding 22.71M
sharesShort 213.86K
sharesShortPriorMonth 341.65K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.03%
Short Ratio help_outline 1.16%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -0.658
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -28.34M
trailingEps -1.83%
forwardEps -0.66%
enterpriseToEbitda -1.05
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.2 3Q 2024
institutionsCount 17
lastUpdated Nov. 7, 2024, 3:31 a.m.